ProCE Banner Activity

How I Work to Improve PARP Inhibitor Access and Outcomes for My Patients With Advanced Ovarian Cancer

Clinical Thought

Review this commentary from a specialty pharmacist on how she and her team provide care for patients with ovarian cancer by helping to increase medication access and improve patient outcomes.

Released: June 22, 2023

Share

Faculty

Emily Hollinghurst

Emily Hollinghurst, PharmD, BCOP, CSP, APh

Assistant Professor
Department of Pharmacy Practice
Loma Linda University, School of Pharmacy
Clinical Pharmacy Specialist
Specialty Pharmacy Services
Loma Linda University Medical Center
Loma Linda, California

Provided by

Provided by ProCE, LLC, in partnership with Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from GSK and Novocure, Inc.

GSK

Novocure, Inc

Partners

Clinical Care Options, LLC

ProCE Banner

Disclosure

Primary Author

Emily Hollinghurst, PharmD, BCOP, CSP, APh

Assistant Professor
Department of Pharmacy Practice
Loma Linda University, School of Pharmacy
Clinical Pharmacy Specialist
Specialty Pharmacy Services
Loma Linda University Medical Center
Loma Linda, California

Emily Hollinghurst, PharmD, BCOP, CSP, APh: consultant/advisor/speaker: Eisai.